Singapore markets open in 5 hours 36 minutes
Straits Times Index
3,331.70 +5.42 (+0.16%) S&P 500
5,466.24 -3.06 (-0.06%) Dow
39,138.82 +26.66 (+0.07%) Nasdaq
17,746.05 +28.40 (+0.16%) Bitcoin USD
60,766.14 -1,170.23 (-1.89%) CMC Crypto 200
1,263.05 -20.73 (-1.61%)
GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS)
NSE - NSE Real-time price. Currency in INR
Add to watchlist
At close: 03:29PM IST
Currency in INR
Valuation measures4
| Market cap (intra-day) | 447.49B |
| Enterprise value | 429.11B |
| Trailing P/E | 75.84 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 13.00 |
| Price/book (mrq) | 25.17 |
| Enterprise value/revenue | 12.47 |
| Enterprise value/EBITDA | 48.34 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.22 |
| 52-week change 3 | 83.63% |
| S&P500 52-week change 3 | 24.96% |
| 52-week high 3 | 2,760.00 |
| 52-week low 3 | 1,377.25 |
| 50-day moving average 3 | 2,307.66 |
| 200-day moving average 3 | 1,973.55 |
Share statistics
| Avg vol (3-month) 3 | 186.87k |
| Avg vol (10-day) 3 | 148.92k |
| Shares outstanding 5 | 169.41M |
| Implied shares outstanding 6 | 169.48M |
| Float 8 | 41.37M |
| % held by insiders 1 | 75.58% |
| % held by institutions 1 | 9.59% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 32 |
| Forward annual dividend yield 4 | 1.21% |
| Trailing annual dividend rate 3 | 32.00 |
| Trailing annual dividend yield 3 | 1.21% |
| 5-year average dividend yield 4 | 1.73 |
| Payout ratio 4 | 91.87% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 31 May 2024 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 11 Sept 2018 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Mar 2024 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 17.08% |
| Operating margin (ttm) | 25.72% |
Management effectiveness
| Return on assets (ttm) | 15.24% |
| Return on equity (ttm) | 33.53% |
Income statement
| Revenue (ttm) | 34.54B |
| Revenue per share (ttm) | 203.87 |
| Quarterly revenue growth (yoy) | 18.10% |
| Gross profit (ttm) | N/A |
| EBITDA | 8.81B |
| Net income avi to common (ttm) | 5.9B |
| Diluted EPS (ttm) | 34.87 |
| Quarterly earnings growth (yoy) | 45.80% |
Balance sheet
| Total cash (mrq) | 18.57B |
| Total cash per share (mrq) | 109.61 |
| Total debt (mrq) | 186.65M |
| Total debt/equity (mrq) | 1.05% |
| Current ratio (mrq) | 1.84 |
| Book value per share (mrq) | 104.93 |
Cash flow statement
| Operating cash flow (ttm) | 5.82B |
| Levered free cash flow (ttm) | 6.7B |
© 2024 Yahoo. All rights reserved.